At the Capital Institute for Neurosciences, our physicians recognize the importance of remaining at the forefront of care and are involved in a variety of research studies. Physicians from the Institute have also been published in leading medical journals and publications.
Among the first to use many newly invented devices for cerebrovascular care the neurosurgeons at the Stroke and Cerebrovascular Center of NJ continue to engage in work to help find new ways of treating stroke and aneurysms.
At Capital Health our team includes neurosurgeons that are frequently among the first to use new devices and treatments including the Merci Retriever, Penumbra device and Onyx glue for aneurysms and AVMs.
Our neurosurgeons are also engaged in studies testing investigational devices. This includes being the first hospital in central and southern New Jersey and Philadelphia to trial Solitaire™, a stroke device now approved by the FDA for clot removal, and the first in the country to trial an investigational device to remove blood clots in acute ischemic stroke patients, the Trevo™ device. We are also participating in studies involving adult stem cells and spinal fusion as well as back pain.